
Sign up to save your podcasts
Or


Lilly releases higher dose Zepbound vials, reduces price for patients paying out of pocket. Meanwhile, the tirzepatide lawsuit heats up, with a potential ruing on preliminary injunction. The OFA strikes up a new battle with the FDA, suing them now over the end of the semaglutide shortage.
š Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP
SOCIALS:
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By Bleav, Dave Knapp Founder of On The Pen4.9
351351 ratings
Lilly releases higher dose Zepbound vials, reduces price for patients paying out of pocket. Meanwhile, the tirzepatide lawsuit heats up, with a potential ruing on preliminary injunction. The OFA strikes up a new battle with the FDA, suing them now over the end of the semaglutide shortage.
š Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP
SOCIALS:
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

333 Listeners

141 Listeners

48 Listeners

106 Listeners

1,643 Listeners

388 Listeners

244 Listeners

217 Listeners

36 Listeners

85 Listeners

168 Listeners

36 Listeners

14 Listeners

43 Listeners

22 Listeners